Cargando…
An Antibody Specific for the Dog Leukocyte Antigen DR (DLA-DR) and Its Novel Methotrexate Conjugate Inhibit the Growth of Canine B Cell Lymphoma
Canine B-cell lymphoma (CBL) is an incurable, spontaneous lymphoid malignancy constituting an accurate animal model for testing novel therapeutic strategies in human medicine. Resources of available species-specific therapeutic monoclonal antibodies (mAbs) targeting CBL are scarce. The aim of the pr...
Autores principales: | Lisowska, Marta, Milczarek, Magdalena, Ciekot, Jarosław, Kutkowska, Justyna, Hildebrand, Wojciech, Rapak, Andrzej, Miazek, Arkadiusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827003/ https://www.ncbi.nlm.nih.gov/pubmed/31561563 http://dx.doi.org/10.3390/cancers11101438 |
Ejemplares similares
-
Large-Scale Polymorphism Analysis of Dog Leukocyte Antigen Class I and Class II Genes (DLA-88, DLA-12/88L and DLA-DRB1) and Comparison of the Haplotype Diversity between Breeds in Japan
por: Miyamae, Jiro, et al.
Publicado: (2023) -
The Effect of Xanthohumol Derivatives on Apoptosis Induction in Canine Lymphoma and Leukemia Cell Lines
por: Grudzień, Małgorzata, et al.
Publicado: (2023) -
The utility of DLA typing for transplantation medicine in canine
models
por: SATO, Keita, et al.
Publicado: (2020) -
Dog leucocyte antigen (DLA) class II haplotypes and risk of canine diabetes mellitus in specific dog breeds
por: Denyer, A. L., et al.
Publicado: (2020) -
Ubiquitin‐specific protease 7 as a potential therapeutic target in dogs with hematopoietic malignancies
por: Pawlak, Aleksandra, et al.
Publicado: (2021)